[ad_1]
Investing.com – Medtronic (NYSE:) reported on Thursday fourth quarter that missed analysts’ forecasts and income that fell wanting expectations.
Medtronic introduced earnings per share of $1.52 on income of $8.09B. Analysts polled by Investing.com anticipated EPS of $1.57 on income of $8.44B.
Medtronic shares are up 2% from the start of the 12 months and are buying and selling at $105.54 , down-from-52-week-high.They’re outperforming the S&P 500 which is down 16.52% 12 months up to now.
Medtronic follows different main Healthcare sector earnings this month
Medtronic’s report follows an earnings missed by Novo Nordisk ADR on Friday, April 29, 2022, who reported EPS of $0.881 on income of $5.96B, in comparison with forecasts EPS of $0.8828 on income of $5.96B.
Pfizer had beat expectations on Tuesday, Might 3, 2022 with first quarter EPS of $1.62 on income of $25.66B, in comparison with forecast for EPS of $1.49 on income of $24.1B.
Keep up-to-date on all the upcoming earnings reviews by visiting Investing.com’s earnings calendar
[ad_2]
Source link
